WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareMedical Distribution
Best Medical Distribution Stocks to Buy Now (2024)
Top medical distribution stocks in 2024 ranked by overall Zen Score. See the best medical distribution stocks to buy now, according to analyst forecasts for the medical distribution industry.

Industry: Medical Distribution
Ticker
Company
Exchange
Industry
Zen Score
Market Cap
Price
1d %
EBITDA
P/E
D/E
MCK
MCKESSON CORP
NYSE
Medical Distribution
$69.29B$527.320.47%$4.53B23.71x-33.22
COR
CENCORA INC
NYSE
Medical Distribution
$47.25B$236.85-0.95%$3.01B25.52x69.79
CAH
CARDINAL HEALTH INC
NYSE
Medical Distribution
$25.01B$102.83-4.95%$1.89B40.01x-14.50
HSIC
HENRY SCHEIN INC
NASDAQ
Medical Distribution
$9.26B$72.041.67%$871.00M22.65x1.48
PDCO
PATTERSON COMPANIES INC
NASDAQ
Medical Distribution
$2.32B$25.91-0.42%$384.69M12.70x2.03
EDAP
EDAP TMS SA
NASDAQ
Medical Distribution
$265.29M$7.15-1.52%-$21.41M-11.53x0.61
ZYXI
ZYNEX INC
NASDAQ
Medical Distribution
$358.38M$11.14-2.11%$18.80M41.26x1.97
AHG
AKSO HEALTH GROUP
NASDAQ
Medical Distribution
$18.64M$0.82-17.58%N/A-3.40x2.21
OMI
OWENS & MINOR INC
NYSE
Medical Distribution
$1.86B$24.23-2.26%$390.57M-44.87x4.51

Medical Distribution Stocks FAQ

What are the best medical distribution stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best medical distribution stocks to buy right now are:

1. Mckesson (NYSE:MCK)


Mckesson (NYSE:MCK) is the top medical distribution stock with a Zen Score of 52, which is 16 points higher than the medical distribution industry average of 36. It passed 20 out of 38 due diligence checks and has strong fundamentals. Mckesson has seen its stock return 45.7% over the past year, overperforming other medical distribution stocks by 13 percentage points.

Mckesson has an average 1 year price target of $555.22, an upside of 5.29% from Mckesson's current stock price of $527.32.

Mckesson stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 9 analysts covering Mckesson, 55.56% have issued a Strong Buy rating, 22.22% have issued a Buy, 22.22% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Cencora (NYSE:COR)


Cencora (NYSE:COR) is the second best medical distribution stock with a Zen Score of 51, which is 15 points higher than the medical distribution industry average of 36. It passed 19 out of 38 due diligence checks and has strong fundamentals. Cencora has seen its stock return 41.23% over the past year, overperforming other medical distribution stocks by 9 percentage points.

Cencora has an average 1 year price target of $235.00, a downside of -0.78% from Cencora's current stock price of $236.85.

Cencora stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cencora, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Cardinal Health (NYSE:CAH)


Cardinal Health (NYSE:CAH) is the third best medical distribution stock with a Zen Score of 50, which is 14 points higher than the medical distribution industry average of 36. It passed 18 out of 38 due diligence checks and has strong fundamentals. Cardinal Health has seen its stock return 26.95% over the past year, underperforming other medical distribution stocks by -5 percentage points.

Cardinal Health has an average 1 year price target of $113.17, an upside of 10.05% from Cardinal Health's current stock price of $102.83.

Cardinal Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Cardinal Health, 33.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 16.67% have issued a Strong Sell.

What are the medical distribution stocks with highest dividends?

Out of 4 medical distribution stocks that have issued dividends in the past year, the 3 medical distribution stocks with the highest dividend yields are:

1. Patterson Companies (NASDAQ:PDCO)


Patterson Companies (NASDAQ:PDCO) has an annual dividend yield of 4.01%, which is 2 percentage points higher than the medical distribution industry average of 1.81%. Patterson Companies's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Patterson Companies's dividend has shown consistent growth over the last 10 years.

Patterson Companies's dividend payout ratio of 51% indicates that its dividend yield is sustainable for the long-term.

2. Cardinal Health (NYSE:CAH)


Cardinal Health (NYSE:CAH) has an annual dividend yield of 1.95%, which is the same as the medical distribution industry average of 1.81%. Cardinal Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cardinal Health's dividend has shown consistent growth over the last 10 years.

Cardinal Health's dividend payout ratio of 77.7% indicates that its dividend yield is sustainable for the long-term.

3. Cencora (NYSE:COR)


Cencora (NYSE:COR) has an annual dividend yield of 0.84%, which is -1 percentage points lower than the medical distribution industry average of 1.81%. Cencora's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cencora's dividend has shown consistent growth over the last 10 years.

Cencora's dividend payout ratio of 21.2% indicates that its dividend yield is sustainable for the long-term.

Why are medical distribution stocks down?

Medical distribution stocks were down -0.51% in the last day, and up 0.31% over the last week. Cardinal Health was the among the top losers in the medical distribution industry, dropping -4.95% yesterday.

Cardinal Health shares are trading lower. The company announced its pharmaceutical distribution contracts with OptumRx will not be renewed and reaffirmed its 2024 EPS guidance.

What are the most undervalued medical distribution stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued medical distribution stocks right now are:

1. Henry Schein (NASDAQ:HSIC)


Henry Schein (NASDAQ:HSIC) is the most undervalued medical distribution stock based on WallStreetZen's Valuation Score. Henry Schein has a valuation score of 86, which is 49 points higher than the medical distribution industry average of 37. It passed 6 out of 7 valuation due diligence checks.

Henry Schein's stock has dropped -15.32% in the past year. It has underperformed other stocks in the medical distribution industry by -48 percentage points.

2. Cencora (NYSE:COR)


Cencora (NYSE:COR) is the second most undervalued medical distribution stock based on WallStreetZen's Valuation Score. Cencora has a valuation score of 57, which is 20 points higher than the medical distribution industry average of 37. It passed 4 out of 7 valuation due diligence checks.

Cencora's stock has gained 41.23% in the past year. It has overperformed other stocks in the medical distribution industry by 9 percentage points.

3. Mckesson (NYSE:MCK)


Mckesson (NYSE:MCK) is the third most undervalued medical distribution stock based on WallStreetZen's Valuation Score. Mckesson has a valuation score of 43, which is 6 points higher than the medical distribution industry average of 37. It passed 3 out of 7 valuation due diligence checks.

Mckesson's stock has gained 45.7% in the past year. It has overperformed other stocks in the medical distribution industry by 13 percentage points.

Are medical distribution stocks a good buy now?

50% of medical distribution stocks rated by analysts are a buy right now. On average, analysts expect medical distribution stocks to rise by 5.88% over the next year.

What is the average p/e ratio of the medical distribution industry?

The average P/E ratio of the medical distribution industry is 25.81x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.